Companies Dominating the Microchips in Medicine Landscape
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Applied Microarrays Inc.
- RELX Group
- QIAGEN
- Agilent Technologies, Inc.
- INTROMEDIC
- Otsuka America Pharmaceutical, Inc.
- Medtronic Plc
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of microchips in medicine is estimated at USD 1.27 billion.
The microchips in medicine market size was over USD 1.14 billion in 2024 and is anticipated to cross USD 2.65 billion by 2037, witnessing more than 6.7% CAGR during the forecast period i.e., between 2025-2037. Increasing popularity of microchip implants in healthcare to improve patient outcomes and the increasing trend of digitalization in healthcare will boost the market growth.
North America industry is estimated to account for largest revenue share of 35% by 2037, impelled by growing spending in healthcare in the region.
The major players in the market are Thermo Fisher Scientific Inc., Applied Microarrays Inc., RELX Group, QIAGEN, Agilent Technologies, Inc., INTROMEDIC, Otsuka America Pharmaceutical, Inc., Medtronic Plc, Illumina, Inc., Bio-Rad Laboratories, Inc.
